Graphic Online
BY: Emmanuel Bruce
705
Bishop Patricia Sappor is an experienced banker with over 30 years experience in Ghana’s banking industry and to crown it all, she is the president of the Ghana Institute of Bankers.
She started her banking career at the erstwhile Bank for Housing and Construction, where she worked for 11 years before moving on to Ecobank, where she worked for over 20 years until her retirement.
At Ecobank, Bishop Sappor rose to become the Head of Corporate Communications.
Recognised as one of the most influential women in Ghana and an honorary fellow of the Institute of Directors Ghana, Bishop Sappor is the first female President of the Chartered Institute of Bankers Ghana.
Nachricht vom 27.05.2021 | 07:30
Gerry Weber International AG: Quarterly statement: GERRY WEBER International AG increases normalised EBITDA despite lockdown in Q1 2021
DGAP-News: Gerry Weber International AG / Key word(s): Interim Report
27.05.2021 / 07:30
Quarterly statement: GERRY WEBER International AG increases normalised EBITDA despite lockdown in Q1 2021
- Online revenues grow by over 54% to EUR 9.1 million
- Coronavirus pandemic sends consolidated revenues falling by 45% to EUR 46.4 million
- At EUR -3.0 million, normalised EBITDA slightly above previous year due to strict cost discipline
- Liquidity currently secured
- Forecast for FY 2021 confirmed
Halle/Westphalia, 27 May 2021 - GERRY WEBER International AG today presented its quarterly statement for the first three months of the fiscal year 2021. The quarterly statement is available online at:
/PRNewswire/ Scania s corporate venture capital-fund announces investment of € 7,5 million in Scantinel to finance further growth in its specialist LiDAR.
Naftogaz appointees to push for change in Ukraine
May 27, 2021 2:20:pm
Summary The new team, which is still being recruited, will focus on thwarting Nord Stream 2, among other goals.
by: William Powell
State-owned Naftogaz Ukrainy CEO Yuri Vitrenko has restructured its team in order to help achieve a major breakthrough in stakeholder relations, implement complex reforms and find .
Posted in:
Share this article
Share this article
NEW YORK, May 27, 2021 /PRNewswire/ Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced it has received European Orphan Drug Designation for SLS-005 in amyotrophic lateral sclerosis (ALS) from the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP).
Under orphan designation in the European Union (EU), Seelos stands to benefit from several incentives such as protocol assistance, reduced regulatory fees and market exclusivity. European guidelines for Orphan Drug Designation are for diseases affecting not more than five in 10,000 people in the EU.